NordiQC Assessments of Synaptophysin Immunoassays.
Journal
Applied immunohistochemistry & molecular morphology : AIMM
ISSN: 1533-4058
Titre abrégé: Appl Immunohistochem Mol Morphol
Pays: United States
ID NLM: 100888796
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
received:
08
01
2021
accepted:
25
08
2021
pubmed:
22
9
2021
medline:
8
3
2022
entrez:
21
9
2021
Statut:
ppublish
Résumé
This paper is number 8 in a series developed through a partnership between ISIMM and NordiQC with the purpose of reporting research assessing the performance characteristics of immunoassays in an external proficiency testing program.
Identifiants
pubmed: 34545849
doi: 10.1097/PAI.0000000000000975
pii: 00129039-202110000-00002
doi:
Substances chimiques
SYP protein, human
0
Synaptophysin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
643-647Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Kwon SE, Chapman ER. Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron. 2011;70:847–854.
Shigematsu K, Nishida N, Sakai H, et al. Synaptophysin immunoreactivity in adrenocortical adenomas: a correlation between synaptophysin and CYP17A1 expression. Eur J Endocrinol. 2009;161:939–945.
Sangoi AR, McKenney JK. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am J Surg Pathol. 2010;34:423–432.
Kepes JJ, Collins J. Choroid plexus epithelium (normal and neoplastic) expresses synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas. J Neuropathol Exp Neurol. 1999;58:398–401.
Rubio CA. Paneth cells and goblet cells express the neuroendocrine peptide synaptophysin. I. Normal duodenal mucosa. In Vivo. 2012;26:135–138.
Morrison CD, Prayson RA. Immunohistochemistry in the diagnosis of neoplasms of the central nervous system. Semin Diagn Pathol. 2000;17:204–215.
Vyberg M, Ulhøi BP, Teglbjaerg PS. Neuronal features of oligodendrogliomas—an ultrastructural and immunohistochemical study. Histopathology. 2007;50:887–896.
Kohmura E, Maruno M, Sawada K, et al. Usefulness of synaptophysin immunohistochemistry in an adult case of choroid plexus carcinoma. Neurol Res. 2000;22:478–480.
Khoddami M, Gholampour Shahaboddini R. Choroid plexus papilloma of the cerebellopontine angle. Arch Iran Med. 2010;13:552–555.
Rodriguez FJ, Scheithauer BW, Robbins PD, et al. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum. Acta Neuropathol. 2007;113:313–324.
Donev K, Scheithauer BW, Rodriguez FJ, et al. Expression of diagnostic neuronal markers and outcome in glioblastoma. Neuropathol Appl Neurobiol. 2010;36:411–421.
Andrew M, Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol. 2020;96:8–33.
Weissferdt A, Phan A, Suster S, et al. Adrenocortical carcinoma: a comprehensive immunohistochemical study of 40 cases. Appl Immunohistochem Mol Morphol. 2014;22:24–30.
Kuroda N, Senzaki T, Yamasaki Y, et al. Sertoli cell tumor of the testis (not otherwise specified) with the expression of neuroendocrine markers and without the expression of inhibin-alpha. Pathol Int. 2004;54:719–724.
Kanehira K, Khoury T. Neuroendocrine markers expression in pancreatic serous cystadenoma. Appl Immunohistochem Mol Morphol. 2011;19:141–146.
Terada T. Expression of NCAM (CD56), chromogranin A, synaptophysin, c-KIT (CD117) and PDGFRA in normal non-neoplastic skin and basal cell carcinoma: an immunohistochemical study of 66 consecutive cases. Med Oncol. 2013;30:444.
Satoh F, Umemura S, Yasuda M, et al. Neuroendocrine marker expression in thyroid epithelial tumors. Endocr Pathol. 2001;12:291–299.
Romano RC, Carter JM, Folpe AL. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases. Mod Pathol. 2015;28:1033–1042.
Setsu N, Kohashi K, Endo M, et al. Inhibin-α and synaptophysin immunoreactivity in synovial sarcoma with granular cell features. Hum Pathol. 2012;43:850–857.
Huang D, Ren F, Ni S, et al. Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity. Cancer Cell Int. 2019;19:310.
Vyberg M, Nielsen S. Proficiency testing in immunohistochemistry--experiences from Nordic Immunohistochemical Quality Control (NordiQC). Virchows Arch. 2016;468:19–29.
Torlakovic EE, Nielsen S, Vyberg M, et al. Getting controls under control: the time is now for immunohistochemistry. J Clin Pathol. 2015;68:879–882.
Erickson LA, Lloyd RV. Practical markers used in the diagnosis of endocrine tumors. Adv Anat Pathol. 2004;11:175–189.
Røge R, Kristoffersen HL, Bzorek M, et al. NordiQC Assessments of Chromogranin A Immunoassays. Appl Immunohistochem Mol Morphol. 2019;27:258–262.
Rosenbaum JN, Guo Z, Baus RM, et al. INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms. Am J Clin Pathol. 2015;144:579–591.
Rooper LM, Bishop JA, Westra WH. INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors. Am J Surg Pathol. 2018;42:665–671.
McHugh KE, Mukhopadhyay S, Doxtader EE, et al. INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas. Am J Clin Pathol. 2020;153:811–820.
Torlakovic EE, Nielsen S, Francis G, et al. Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee. Appl Immunohistochem Mol Morphol. 2015;23:1–18.